Hirokazu Murakami

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 2

Top Topics

Long Non Coding Rna

Tyrosine Kinase

Multiple Myeloma

Inflammatory Response

Top Venues

Future oncology (London, England)

Cancer gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Akira Kawasaki, Hirokazu Murakami, Takaaki Chou, Masaru Matsushita, Masahiro Kizaki
Post-marketing surveillance of carfilzomib in Japanese patients with relapsed or refractory multiple myeloma. Future oncology (London, England) 18 (24) (2022)
Tsukasa Oda, Ruri Nakamura, Tetsuhiro Kasamatsu, Nanami Gotoh, Keiko Okuda, Takayuki Saitoh, Hiroshi Handa, Hirokazu Murakami, Takayuki Yamashita
DNA-double strand breaks enhance the expression of major histocompatibility complex class II through the ATM-NF-κΒ-IRF1-CIITA pathway. Cancer gene therapy (2021)